29 June 2023
: Case report
Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare coexistence of disease or pathology
Christopher R. Grant1ABCDEF*, Elaine J. Chiao1EF, Zhaohui L. Arter2ADE, Cary Johnson3C, Truc Tran3BE, Farshid Dayyani2E, Krishnasu Tewari2E, Valery Vilchez4E, Joseph Carmichael
DOI: 10.12659/AJCR.939448
Am J Case Rep 2023; 24:e939448
Related articles
Coming soon...
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949330
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947938
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947163
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949194
Most Viewed Current Articles
21 Jun 2024 : Case report
101,695
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,424
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
37,967
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,852
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200